NEPHROS INC
NEPHNASDAQTrading Snapshot
- Day Range
- $3.11 β $3.51
- 52-Week Range
- $2.66 β $6.42
- Volume (shares)
- 236,015
- Avg Volume (shares)
- β
- Shares Outstanding
- 10.9M
- Next Earnings
- 2026-11-05
Fundamentals Snapshot
- Annual Revenue
- $19M
- Last Q Revenue
- $6M
- P/E Ratio
- 19.7
- P/S Ratio
- 1.7x
- EPS (TTM)
- $0.16
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +3.9%
NEPHROS INC
NEPHAbout NEPHROS INC
Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products. These are vital in dialysis centers for eradicating biological contaminants from water and bicarbonate concentrate, and are also deployed in hospitals to prevent infections from waterborne pathogens such as Legionella and Pseudomonas. Their utility extends to military installations, outdoor recreation, commercial establishments, and various other healthcare facilities. The Pathogen Detection segment focuses on developing and distributing real-time water testing systems, which deliver critical, actionable data regarding waterborne pathogens. Furthermore, under its Renal Products segment, the company provides medical devices designed for individuals suffering from renal disease, notably including a second-generation hemodiafiltration system tailored for patients with end-stage renal disease. Additionally, Nephros markets a range of water filters under the Nephros and AETHER brands. These filters are engineered not only to enhance water taste and eliminate odors but also to significantly reduce biofilm, bacteria, and scale accumulation in downstream equipment, serving the food service, hospitality, convenience store, and healthcare industries. Established in 1997, Nephros, Inc. maintains its corporate headquarters in South Orange, New Jersey.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
βLatest News & Updates

Contrasting Nephros (NASDAQ:NEPH) & Nyxoah (NASDAQ:NYXH)
Nyxoah (NASDAQ: NYXH - Get Free Report) and Nephros (NASDAQ: NEPH - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength o

Nephros Q2 Earnings Call Highlights
Nephros (NASDAQ: NEPH) reported record second-quarter revenue and sharply higher profitability, as growth in its recurring programmatic product business and service offerings helped drive results. Revenue for the three m

Nephros, Inc. (NEPH) Q2 2026 Earnings Call Transcript
Nephros, Inc. (NEPH) Q2 2026 Earnings Call Transcript

Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026
Record Second-Quarter Net Revenue Growth of 36% to $6 millionCore Programmatic Revenue Grew by 27% Year Over Year SOUTH ORANGE, NJ, August 6, 2026 β PRISM MediaWire (Press Release Service β Press Release Distribution) β

Nephros Schedules Second Quarter 2026 Financial Results Conference Call
SOUTH ORANGE, N.J., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will fi